Character Biosciences

Character Biosciences is dedicated to providing groundbreaking precision medicine solutions for polygenic diseases. Our expanding therapeutic pipeline focuses on developing breakthrough treatments aimed at addressing diseases with significant unmet medical needs. Our research team is rapidly advancing preclinical programs, primarily targeting dry age-related macular degeneration (AMD) and primary open-angle glaucoma (POAG).